Titan PharmaceuticalsTTNP
13F holders, Q2 2025 (June 30)At the end of Q2 2025, 20 institutions reported holding Titan Pharmaceuticals Inc. (TTNP) in their 13F filings, up 3 from Q1 2025. 3 opened new positions and 0 sold out. The largest holders were Citadel Advisors ($51K), Renaissance Technologies ($48K) and Marex Group Ltd ($45K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Titan Pharmaceuticals Inc.
- CUSIP
- 888314705
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $93K |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 22,985 shares bought and 7 shares sold, net +22,978 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| Citadel Advisors | 0.00% | Add +0.9% | 12,069 | $51K |
| Renaissance Technologies | 0.00% | New | 11,380 | $48K |
| Marex Group Ltd | 0.00% | New | 10,663 | $45K |
| UBS Group AG | 0.00% | Add +32.1% | 3,427 | $14K |
| CoreCap Advisors, LLC | 0.00% | No change | 88 | $370 |
| Bank of America Corp. | 0.00% | No change | 18 | $75 |
| Group One Trading LLC | 0.00% | No change | 12 | $50 |
| Osaic Holdings, Inc. | 0.00% | Reduce -33.3% | 10 | $40 |
| BlackRock, Inc. | 0.00% | No change | 6 | $25 |
| Morgan Stanley | 0.00% | Reduce -50.0% | 2 | $8 |
| Global Wealth Strategies & Associates | 0.00% | No change | 2 | $8 |
| Wells Fargo & Company | 0.00% | No change | 1 | $4 |
| Caldwell Sutter Capital, Inc. | 0.00% | No change | 1 | $4 |
| Raymond James Financial Inc. | 0.00% | New | 1 | $4 |
| St Germain D J Co. Inc. | 0.00% | No change | 1 | $4 |
| Westside Investment Management, Inc. | 0.00% | No change | 1 | $4 |
| SBI Securities Co., Ltd. | 0.00% | No change | 1 | $4 |
| Cape Investment Advisory, Inc. | 0.00% | No change | 1 | $4 |
| Nemes Rush Group LLC | 0.00% | No change | 1 | $4 |
| Ransom Advisory, Ltd | 0.00% | No change | 1 | $4 |
"% of holder's portfolio" is TTNP's weight in each manager's 13F, not the share of Titan Pharmaceuticals Inc. the manager owns.